SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/22/16 Emmaus Life Sciences, Inc. 10-K 9/30/16 71:6.7M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 882K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 105K 3: EX-4.4 Instrument Defining the Rights of Security Holders HTML 35K 4: EX-4.5 Instrument Defining the Rights of Security Holders HTML 51K 5: EX-4.6 Instrument Defining the Rights of Security Holders HTML 50K 6: EX-10.23 Material Contract HTML 35K 7: EX-10.24 Material Contract HTML 59K 8: EX-21.1 Subsidiaries List HTML 17K 9: EX-23.1 Consent of Experts or Counsel HTML 19K 10: EX-31.1 Certification -- §302 - SOA'02 HTML 25K 11: EX-31.2 Certification -- §302 - SOA'02 HTML 25K 12: EX-32.1 Certification -- §906 - SOA'02 HTML 21K 13: EX-32.2 Certification -- §906 - SOA'02 HTML 21K 20: R1 Document and Entity Information HTML 49K 21: R2 Consolidated Balance Sheets HTML 110K 22: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K 23: R4 Consolidated Statements of Operations HTML 70K 24: R5 Consolidated Statements of Changes in HTML 63K Stockholders' Deficit 25: R6 Consolidated Statements of Cash Flows HTML 100K 26: R7 Nature of Operations HTML 41K 27: R8 Summary of Significant Accounting Policies HTML 66K 28: R9 Convertible Debt and Equity Financings HTML 136K 29: R10 Derivative Liabilities HTML 59K 30: R11 Stockholders' Deficit HTML 127K 31: R12 Income Taxes HTML 45K 32: R13 Related Party Transactions HTML 40K 33: R14 Loss Per Share HTML 36K 34: R15 Commitments and Contingent Liabilities HTML 55K 35: R16 Significant Customers HTML 25K 36: R17 Subsequent Events HTML 41K 37: R18 Summary of Significant Accounting Policies HTML 125K (Policies) 38: R19 Summary of Significant Accounting Policies HTML 28K (Tables) 39: R20 Convertible Debt and Equity Financings (Tables) HTML 114K 40: R21 Derivative Liabilities (Tables) HTML 50K 41: R22 Stockholders' Deficit (Tables) HTML 103K 42: R23 Income Taxes (Tables) HTML 43K 43: R24 Loss Per Share (Tables) HTML 33K 44: R25 Commitments and Contingent Liabilities (Tables) HTML 34K 45: R26 Nature of Operations (Details Narrative) HTML 62K 46: R27 Summary of Significant Accounting Policies HTML 30K (Details) 47: R28 Summary of Significant Accounting Policies HTML 75K (Details Narrative) 48: R29 Convertible Debt and Equity Financings (Details) HTML 110K 49: R30 Convertible Debt and Equity Financings (Details HTML 105K Narrative) 50: R31 Derivative Liabilities (Details) HTML 30K 51: R32 Derivative Liabilities (Details 1) HTML 57K 52: R33 Derivative Liabilities (Details Narrative) HTML 86K 53: R34 Stockholders' Deficit (Details) HTML 28K 54: R35 Stockholders' Deficit (Details 1) HTML 42K 55: R36 Stockholders' Deficit (Details 2) HTML 100K 56: R37 Stockholders' Deficit (Details 3) HTML 45K 57: R38 Stockholders' Deficit (Details 4) HTML 50K 58: R39 Stockholders' Deficit (Details Narrative) HTML 203K 59: R40 Stockholders' Deficit (Details Narrative 1) HTML 55K 60: R41 Income Taxes (Details) HTML 37K 61: R42 Income Taxes (Details 1) HTML 42K 62: R43 Income Taxes (Details Narrative) HTML 25K 63: R44 Related Party Transactions (Details Narrative) HTML 88K 64: R45 Loss Per Share (Details) HTML 39K 65: R46 Commitments and Contingent Liabilities (Details) HTML 56K 66: R47 Commitments and Contingent Liabilities (Details HTML 107K Narrative) 67: R48 Significant Customers (Details Narrative) HTML 30K 68: R49 Subsequent Events (Details Narrative) HTML 109K 70: XML IDEA XML File -- Filing Summary XML 111K 69: EXCEL IDEA Workbook of Financial Reports XLSX 89K 14: EX-101.INS XBRL Instance -- myan-20160930 XML 2.01M 16: EX-101.CAL XBRL Calculations -- myan-20160930_cal XML 143K 17: EX-101.DEF XBRL Definitions -- myan-20160930_def XML 731K 18: EX-101.LAB XBRL Labels -- myan-20160930_lab XML 1.10M 19: EX-101.PRE XBRL Presentations -- myan-20160930_pre XML 922K 15: EX-101.SCH XBRL Schema -- myan-20160930 XSD 169K 71: ZIP XBRL Zipped Folder -- 0001615774-16-009049-xbrl Zip 163K
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 12/22/16 | 8-K | ||
For Period end: | 9/30/16 | |||
9/30/15 | 10-K, 8-K, CORRESP, NT 10-K, PRER14A | |||
1/8/15 | ||||
9/30/14 | 10-K, 10-K/A, D | |||
8/3/06 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/22 Emmaus Life Sciences, Inc. 10-K 12/31/21 98:18M ActiveDisclosure/FA 8/10/21 Emmaus Life Sciences, Inc. 10-K/A 12/31/20 92:18M ActiveDisclosure/FA 5/04/21 Emmaus Life Sciences, Inc. 10-K 12/31/20 97:18M ActiveDisclosure/FA 1/25/21 Emmaus Life Sciences, Inc. 10-K 12/31/19 121:29M ActiveDisclosure/FA |